T

Tellus BioVentures

4 employees

Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation.

Investor insights

Sectors invested in

Biotechnology6
Biopharma5
Pharmaceutical5
Health Care5
Therapeutics3
Clinical Trials1
Cell engineering1
Cancer1
CD71
CART immunotherapy1
Hematology1
Test and Measurement1
Physician1
Leukemia1
DIAGNOSIS1
CD301
Bioinformatics1
CRISPR1
Myeloma1
Gene editing1

Funding rounds participated in

$10M sweet spot round size

Most of their 8 investments are in rounds between $5.5M and $76M

Basic info

Industry

venture capital and private equity principals

Date founded

2019

Investments made

Z

Zenas BioPharma raised $118M on November 7, 2022

Investors: -, Longitude Capital, Xencor, Vivo Capital, Quan Capital 泉创资本, Perceptive Advisors, Wellington Management and Tellus BioVentures

v

viTToria biotherapeutics raised $10M on June 7, 2022

Investors: SV Life Sciences, Agent Capital and Tellus BioVentures

D

Dianthus Therapeutics, Inc. raised $100M on April 19, 2022

Investors: 5AM Ventures, Avidity Partners, Wedbush Securities and Tellus BioVentures

N

Navrogen raised $3M on August 9, 2021

Investors: Tellus BioVentures

I

Interius BioTherapeutics raised $76M on May 18, 2021

Investors: Knollwood Investment Advisory, Quan Capital 泉创资本, Longwood Fund, Logos Global Management, LP, RA Capital Management, L.P., Osage University Partners (OUP) and Tellus BioVentures

Z

Zenas BioPharma raised undisclosed on March 23, 2021

Investors: Quan Capital 泉创资本, Wellington Management and Tellus BioVentures

A

Aegle Therapeutics raised $6.5M on September 29, 2020

Investors: New World Angels, DEFTA Partners, Ocean Azul Partners, FAN Fund and Tellus BioVentures

I

Interius BioTherapeutics raised $5.5M on March 13, 2020

Investors: Agent Capital and Tellus BioVentures

FAQ